The role of vitamin D receptor gene alleles in the secondary hyperparathyroidism of hemodialysis patients

Journal of Nephrology

Volumn 9, Issue 4, 1996, Pages 201-206

  Aterini, Stefano ^a,d   Salvadori, Marco ^a   Ippolito, Emilia ^a   Petrocelli, Paola ^b   Pacini, Stefania ^b   Sineo, Luca ^c   Martini, Remo ^c   Failli, Manuela ^c   Amato, Marcello ^a   Ruggiero, Marco ^b  

^a Hospital of Prato   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Fanfani Clinical Research Institute   (Italy)

^d MISERICORDIA E DOLCE HOSPITAL   (Italy)

Author keywords

bone mineral density; dialysis; hyperparathyroidism; parathyroid hormone; vitamin D receptor gene

Indexed keywords

CALCITRIOL; VITAMIN D RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS; HUMAN; MALE; SECONDARY HYPERPARATHYROIDISM;

EID: 10144229358     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Llach F. Secondary hyperparathyroidism in renal failure. The trade-off hypothesis revisited. Am J Kidney Dis 1995; 25: 663-79.
2. Slatopolsky E, Berkoben M, Kelber J, Brown A, Delmez J. Effects of calcitriol and non-calcemic Vitamin D analogues on secondary hyperparathyroidism. Kidney Int 1992; 42 (Suppl 38): S43-9.
3. Hsu CH, Patel SR, Young EW, Vanholder R. The biological action of calcitriol in renal failure. Kidney Int 1994; 46: 605-12.
4. Morrison NA, Cheng QI J, et al. Prediction of bone density from calcitriol receptor alleles. Nature 1994; 367: 284-7.
5. Kanis JA. Osteoporosis. Oxford: Blackwell Science Ltd, 1994; 212.
6. Tilyard MW, Spears GFS, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992; 362: 357-62.
7. 3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637-42.
8. De Broe ME, D'Haese PC, Van de Vyver FL. Aluminum toxicity. In: Daugirdas JT, Ing TS, eds. Handbook of dialysis. Boston: Little, Brown and Company 1988; 397-408.
9. Carlberg C, Bendik I, Wyss A, et al. Two nuclear signalling pathways for calcitriol. Nature 1993; 361: 657-60.
10. 3. Proc Natl Acad Sci USA 1992; 89: 8097-101.
11. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA 1992; 89: 6665-9.
12. Howard G, Nguyen T, Morrison N, et al. Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab 1995; 80: 2800-5.
13. Patel SR, Ke HQ, Hsu CH. Regulation of calcitriol receptor and its mRNA in normal and renal failure rats. Kidney Int 1994; 45: 1020-7.
14. Patel SR, Qiong Ke H, Vanholder R, Hsu CH. Inhibition of nuclear uptake of calcitriol receptor by uremic ultrafiltrate. Kidney Int 1994; 46: 129-33.
15. Hsu CH, Patel SR, Young EW. Mechanism of decreased calcitriol degradation in renal failure. Am J Physiol 1992; 262: F192-8.
16. 3 receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 1989; 35: 19-23.
17. Hsu CH, Patel RS, Vanholder R. Mechanism of decreased intestinal calcitriol receptor concentration in renal failure. Am J Physiol 1993; 264: F662-9.
18. 3 receptors and duodenal calbindin-D9k in uremic rats. Eur J Clin Invest 1991; 21: 521-6.
19. Kremer R, Bolivar I, Goltzman D, Hendy GN. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 1989; 125: 935-41.
20. 3. Immunology 1986; 59: 269-74.
21. 3. Proc Natl Acad Sci USA 1987; 84: 856-63.
22. Reitsma PH, Rothberg PG, Astun SM, et al. Regulation of myc gene expression in HL-60 leukemia cells by a vitamin D metabolite. Nature 1983; 306: 492-7.
23. Carling T, Kindmark A, Hellman P, et al. Vitamin D receptor genotypes in primary hyperparathyroidism. Nature Med 1995; 1: 1309-11.
24. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-43.
25. Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drueke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95: 2047-53.
26. Falchetti A, Bale AE, Amorosi A, et al. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 1993; 70: 139-44.
27. Brown EM, Pollak MR, Seidman CE, et al. Calcium-ion-sensing cell-surface receptors. N Engl J Med 1995; 333: 234-40.
28. Rickers H, Christensen M, Podbro P. Bone mineral content in patients on prolonged maintenance hemodialysis: a three year follow-up study. Clin Nephrol 1983; 20: 302-7.
29. Lindergard B, Johnell BO, Nilsson BE, Wiklund PE. Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment. Nephron 1985; 39: 122-9.
30. Asaka M, Ida H, Entani C, et al. Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis. Clin Nephrol 1992; 38: 149-53.
31. Eeckhout E, Verbeelen D, Sennesael J, Kaufman L, Jonckheer MH. Monitoring of bone mineral content in patients on regular hemodialysis. Nephron 1989; 52: 158-61.
32. 3, and radiology in end-stage renal failure. Kidney Int 1993; 44: 1071-7.
33. Krieger NS, Sessler NE, Bushinsky DA. Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol 1992; 262: F442-8.
34. Malluche H, Faugere MC. Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 1990; 38: 193-211.
35. Felsenfeld AJ, Llach F. Parathyroid gland function in chronic renal failure. Kidney Int 1993; 43: 771-89.
36. Ralston SH. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 1994; 9: 883-90.
37. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995; 332: 305-11.
38. Manolagas SC, Jilka RL, Girasole G, Passeri G, Bellido T. Estrogens, cytokines, and the pathophysiology of osteoporosis. Current Opin Endocrinol Diab 1994; 1: 275-81.
39. Kimble RB, Vannice JL, Bloedow DC. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 1994; 93: 1959-67.
40. Pereira BJG, Dinarello CA. Production of cytokines and cytokine inhibitory proteins in patients on dialysis. Nephrol Dial Transplant 1994; 9 (Suppl 2): 60-71.
41. Moe SM, Hack BK, Cummings SA, Sprague SM. Role of IL-1β and prostaglandins in β2-microglobulin-induced bone mineral dissolution. Kidney Int 1995; 47: 587-91.